No Data
Press Release: Humacyte Announces Pricing of $30.0 Million Registered Direct Offering
Humacyte Price Target Maintained With a $25.00/Share by EF Hutton
Humacyte Is Maintained at Buy by EF Hutton
Humacyte to Participate in a Conference Call With Benchmark
Analysts Conflicted on These Healthcare Names: Humacyte (HUMA) and Baxter International (BAX)
Humacyte, Inc. (HUMA) Increases Yet Falls Behind Market: What Investors Need to Know
10baggerbamm : the mkt is week and people are closing out positions in they had short term profits in .